Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

NCT06850545 is registered in ClinicalTrials.gov with Kuopio University Hospital as lead sponsor.

NCT NCT06850545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06850545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer
Lead sponsor
Kuopio University Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2020
Completion date
December 31, 2035
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate adenocarcinoma, psma pet-positive castration-resistant prostate cancer